#addimmune search results
Happy #Women’sEqualityDay! #Addimmune recognizes the brilliant women who fought for #WomensSuffrage, and those who continue to fight for #genderequality today.
#HIVClinicalTrialUpdate: Phase 1 is complete and #Addimmune is designing protocol for the next phase of the clinical trial. #ATI results showed promising data and significant viral suppression! There’s more work to be done, but the data is encouraging.
BREAKING: #Addimmune to go public through a #business combination with @10XCapitalVC! Find out more here. hubs.li/Q01-HDl60
@WhitmanWalker is holding their 37th Annual Walk to #EndHIV. Join the #Addimmune team to raise funds to support WWH’s mission to fight #stigma and provide accessible #healthcare to those living with or affected by #HIV/#AIDS. hubs.li/Q0252smh0
It was an honor to host @MarilynBalcombe at our #Rockville office! Thank you, Councilmember Balcombe, for all of the amazing work you do for #MontgomeryCounty – #Addimmune looks forward to your continued support as we pursue a cure for #HIV!
#Addimmune is participating in the #WalktoEndHIV with @WhitmanWalker in #DC. Join us on October 21st to raise funds to support WWH’s mission of providing dependable, high-quality & accessible #healthcare to those living with or affected by #HIV/#AIDS. hubs.li/Q023Cyqk0
The Phase 1 trial has been completed & #Addimmune is designing Phase 2 protocol. As the data is being reviewed, we’ve noted promising results & significant viral suppression after #ATI but there's still more work to be done! Follow @Addimmune for updates. bit.ly/46v8sxJ
Joining YouTube creator and #HIVactivist @raifderrazi, CEO @JeffreyGalvin discusses #Addimmune’s next steps after a successful #HIV Phase 1 clinical trial. Watch here for a look into our plan to advance research in pursuit of an #HIVcure. bit.ly/3NIZp3y
youtube.com
YouTube
HIV Cure Clinical Trial AGT103-T & Addimmune | Jeff Galvin x Raif...
After 15 years of work with @americangene, CEO @JeffreyGalvin shares the reasoning behind the launch of #Addimmune – a spinoff company focused on advancing research towards an #HIVcure. Watch on CityBiz’s #CEOInterviews series. bit.ly/3XMcZbf
Interviewed by @raifderrazi: CEO @JeffreyGalvin shares insight on the AGT103-T #HIV Phase 1 clinical trial and #Addimmune’s plans for Phase 2. Watch here. bit.ly/3CZ26Jw
youtube.com
YouTube
HIV Cure Clinical Trial AGT103-T & Addimmune | Jeff Galvin x Raif...
@WhitmanWalker is holding their 37th Annual Walk to #EndHIV. Join the #Addimmune team to raise funds to support WWH’s mission to fight #stigma and provide accessible #healthcare to those living with or affected by #HIV/#AIDS. hubs.li/Q0252GWJ0
#Addimmune is participating in the #WalktoEndHIV with @WhitmanWalker in #DC. Join us on October 21st to raise funds to support WWH’s mission of providing dependable, high-quality & accessible #healthcare to those living with or affected by #HIV/#AIDS. hubs.li/Q023CC7l0
We’ve entered a merger agreement with @10XCapitalVC! “10X is proud to support #Addimmune in advancing its mission of curing #HIV.” - Hans Thomas, Chairman and CEO of 10X III. Read more here. hubs.li/Q0206zfD0
@Addimmune has entered a merger agreement with @10XCapitalVC! “10X is proud to support #Addimmune in advancing its mission of curing #HIV.” - Hans Thomas, Chairman and CEO of 10X III. Read more here. bit.ly/44nCeSE
In case you missed the party: #Addimmune was launched with the sole purpose of curing HIV! We had the pleasure of hosting elected government officials, #LifeSciences enthusiasts and our passionate supporters who want to see an end to #HIV. Watch here. hubs.li/Q01YHxY20
youtube.com
YouTube
Addimmune™ Launch Party Highlights
AGT103-T, #Addimmune’s single-infusion autologous #celltherapy, is designed to act as a functional #cure for #HIV – meaning patients would never develop #AIDS, require #antiretroviral therapy, or spread HIV. Read on Precision Medicine Online. hubs.li/Q01ZPCyb0
#HIVClinicalTrialUpdate: Phase 1 is complete and #Addimmune is designing protocol for Phase 2. #ATI results showed promising data and significant viral suppression! There’s more work to do, but the data is encouraging. Follow @Addimmune for updates. bit.ly/44tYCKM
@Addimmune has entered a merger agreement with @10XCapitalVC! “10X is proud to support #Addimmune in advancing its mission of curing #HIV.” - Hans Thomas, Chairman and CEO of 10X III. Read more here. bit.ly/3P6ABVe
Addimmune: This Company Is Laser-Focused On Ending The HIV Epidemic dlvr.it/T26zYC #Profiles #Addimmune
pulse2.com
Addimmune: This Company Is Laser-Focused On Ending The HIV Epidemic
Addimmune is a company that is changing the way that HIV is treated. With the company’s pioneering gene therapy approach, Addimmune believes HIV will no longer be a life-long sentence – but a curable...
@WhitmanWalker is holding their 37th Annual Walk to #EndHIV. Join the #Addimmune team to raise funds to support WWH’s mission to fight #stigma and provide accessible #healthcare to those living with or affected by #HIV/#AIDS. hubs.li/Q0252smh0
#Addimmune is participating in the #WalktoEndHIV with @WhitmanWalker in #DC. Join us on October 21st to raise funds to support WWH’s mission of providing dependable, high-quality & accessible #healthcare to those living with or affected by #HIV/#AIDS. hubs.li/Q023Cyqk0
#Addimmune is participating in the #WalktoEndHIV with @WhitmanWalker in #DC. Join us on October 21st to raise funds to support WWH’s mission of providing dependable, high-quality & accessible #healthcare to those living with or affected by #HIV/#AIDS. hubs.li/Q023CC7l0
Building on encouraging Phase I results, #Addimmune is working towards launching a Phase II trial to establish its #HIV #genetherapy #treatment efficacy. Read on Precision Medicine Online. hubs.li/Q02087Bm0
We’ve entered a merger agreement with @10XCapitalVC! “10X is proud to support #Addimmune in advancing its mission of curing #HIV.” - Hans Thomas, Chairman and CEO of 10X III. Read more here. hubs.li/Q0206zfD0
@Addimmune has entered a merger agreement with @10XCapitalVC! “10X is proud to support #Addimmune in advancing its mission of curing #HIV.” - Hans Thomas, Chairman and CEO of 10X III. Read more here. bit.ly/3P6ABVe
@Addimmune has entered a merger agreement with @10XCapitalVC! “10X is proud to support #Addimmune in advancing its mission of curing #HIV.” - Hans Thomas, Chairman and CEO of 10X III. Read more here. bit.ly/44nCeSE
DA: 临床阶段艾滋病毒基因治疗公司 #Addimmune 将通过与 10x Capital Venture Acquisition Corp. III $VCXB 的业务合并上市,新闻:spac.mg21.com/merger/8466.ht…,百科:mg21.com/hiv.html
Joining YouTube creator and #HIVactivist @raifderrazi, CEO @JeffreyGalvin discusses @Addimmune’s next steps after a successful #HIV Phase 1 clinical trial. Watch here for a look into #Addimmune’s plan to advance research in pursuit of an #HIVcure. bit.ly/44fhoFQ
youtube.com
YouTube
HIV Cure Clinical Trial AGT103-T & Addimmune | Jeff Galvin x Raif...
#HIVClinicalTrialUpdate: Phase 1 is complete and #Addimmune is designing protocol for Phase 2. #ATI results showed promising data and significant viral suppression! There’s more work to do, but the data is encouraging. Follow @Addimmune for updates. bit.ly/44tYCKM
The Phase 1 trial has been completed & #Addimmune is designing Phase 2 protocol. As the data is being reviewed, we’ve noted promising results & significant viral suppression after #ATI but there's still more work to be done! Follow @Addimmune for updates. bit.ly/46v8sxJ
“If you look at #DNA in your body it behaves a lot like software in an organic computer” - CEO @JeffreyGalvin joins @raifderrazi to discuss #Addimmune’s mission to harness #genetherapy in pursuit of an #HIVcure. Watch here. bit.ly/44x1oif
Happy #Women’sEqualityDay! #Addimmune recognizes the brilliant women who fought for #WomensSuffrage, and those who continue to fight for #genderequality today.
It was an honor to host @MarilynBalcombe at our #Rockville office! Thank you, Councilmember Balcombe, for all of the amazing work you do for #MontgomeryCounty – #Addimmune looks forward to your continued support as we pursue a cure for #HIV!
#HIVClinicalTrialUpdate: Phase 1 is complete and #Addimmune is designing protocol for the next phase of the clinical trial. #ATI results showed promising data and significant viral suppression! There’s more work to be done, but the data is encouraging.
After 15 years of work with @americangene, CEO @JeffreyGalvin shares the reasoning behind the launch of #Addimmune – a spinoff company focused on advancing research towards an #HIVcure. Watch on CityBiz’s #CEOInterviews series. bit.ly/3XMcZbf
#Addimmune is participating in the #WalktoEndHIV with @WhitmanWalker in #DC. Join us on October 21st to raise funds to support WWH’s mission of providing dependable, high-quality & accessible #healthcare to those living with or affected by #HIV/#AIDS. hubs.li/Q023Cyqk0
@WhitmanWalker is holding their 37th Annual Walk to #EndHIV. Join the #Addimmune team to raise funds to support WWH’s mission to fight #stigma and provide accessible #healthcare to those living with or affected by #HIV/#AIDS. hubs.li/Q0252smh0
@WhitmanWalker is holding their 37th Annual Walk to #EndHIV. Join the #Addimmune team to raise funds to support WWH’s mission to fight #stigma and provide accessible #healthcare to those living with or affected by #HIV/#AIDS. hubs.li/Q0252GWJ0
#Addimmune is participating in the #WalktoEndHIV with @WhitmanWalker in #DC. Join us on October 21st to raise funds to support WWH’s mission of providing dependable, high-quality & accessible #healthcare to those living with or affected by #HIV/#AIDS. hubs.li/Q023CC7l0
Something went wrong.
Something went wrong.
United States Trends
- 1. Jokic 25.7K posts
- 2. Lakers 53.8K posts
- 3. Epstein 1.66M posts
- 4. #AEWDynamite 50.1K posts
- 5. #River 4,986 posts
- 6. Nemec 3,325 posts
- 7. Clippers 14.4K posts
- 8. Shai 16.5K posts
- 9. #ReasonableDoubtHulu N/A
- 10. Thunder 42.5K posts
- 11. #NJDevils 3,109 posts
- 12. Markstrom 1,252 posts
- 13. Ty Lue 1,120 posts
- 14. #Blackhawks 1,603 posts
- 15. Nemo 8,810 posts
- 16. Mikey 71.6K posts
- 17. Lafferty N/A
- 18. Rory 8,168 posts
- 19. Steph 30.2K posts
- 20. Jordan Miller N/A